HomeOpen Access NewsAlzheimer's Disease

Alzheimer's Disease

APOE protein variants affect microglia response in Alzheimer’s disease

A new study investigates how APOE isoforms differentially affect human microglia function in Alzheimer's disease.

Enhancing deep sleep can help prevent dementia

A study has revealed that a 1 % decrease in deep sleep each year among individuals aged 60 and older can lead to a 27 % rise in the risk of developing dementia.

Ensuring adequate dementia care: The beginning of the end of Alzheimer’s?

Colin Capper, Associate Director of Evidence and Involvement at Alzheimer’s Society, argues that we need improved dementia care and further innovations for people living with dementia today while we wait for the breakthroughs of tomorrow

Shedding a light onto Alzheimer’s disease awareness

Every year, the 21st of September is dedicated to raising awareness for Alzheimer's disease and other forms of dementia, so today, we look at...

Blocking brain cell death shows promise in new Alzheimer’s treatment

Blocking the MEG3 molecule holds promise as a potential Alzheimer's treatment by delaying brain cell death.

Breakthrough blood test to detect Alzheimer’s disease

A new groundbreaking blood test, p-tau217, holds potential as an Alzheimer's disease indicator. When incorporated into a two-step process, it demonstrates exceptional accuracy in detecting or ruling out brain amyloidosis, a crucial early sign.

Wearable night headband detects early stages of Alzheimer’s

New research reveals a wearable night headband capable of identifying early biomarkers for Alzheimer's disease in asymptomatic adults.

Can poor oral hygiene lead to dementia?

Dr Deborah Lee from Dr Fox Pharmacy shares evidence on the link between poor mouth care and dementia risk, and the steps needed to promote better oral hygiene.

Dementia risk linked to disadvantaged neighbourhoods

Dementia risk linked to neighbourhood disadvantage among Veterans Health Administration enrollees, studied using the Area Deprivation Index.

Experimental Alzheimer’s drug slows progression of early disease

An experimental Alzheimer's drug called donanemab, developed by Eli Lilly, has demonstrated a slowdown in progression of disease at early stages, according to trial data.

Sleep apnea patients have higher risk of stroke, Alzheimer’s, and cognitive decline

Sleep apnea patients with reduced deep sleep have a greater risk of brain biomarkers linked to stroke, Alzheimer's, and cognitive decline.

Link between premature menopause, later hormone therapy and Alzheimer’s disease

Researchers are investigating the role of tau in the link between early menopause, delayed hormone therapy and Alzheimer's disease.

Getting enough sleep is vital for healthy ageing

Dr Deborah Lee from Dr Fox Online Pharmacy analyses insomnia in the UK and why getting enough sleep is vital for healthy ageing.

Overcoming global inequities in cognitive healthcare to combat dementia

CEO of ViewMind Inc, Mark Edwards, discusses overcoming global inequities in cognitive healthcare to combat the dementia epidemic.

Treatments for Alzheimer’s disease: understanding causes, diagnosis, prevention & cure

Abbas Kanani, Superintendent Pharmacist at Chemist Click Online Pharmacy, walks us through treatments for Alzheimer’s disease, researching the causes, diagnosis, prevention, and cure.

Understanding amyloid beta and Alzheimer’s disease: the key to helping AD patients

Efforts to prevent or treat Alzheimer’s Disease (AD) by targeting Amyloid beta (Aβ) assemblies should be continued, but the strategies should be altered dramatically.

Understanding Amyloidosis, a group of rare diseases

In this interview, Abbas Kanani, MRPharmS, Superintendent Pharmacist at Chemist Click, tells us about amyloidosis, a group of rare diseases in which abnormal proteins deposit as amyloid in tissues and organs.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders